Using oncolytic viruses to enhance trafficking and infiltration of chimeric antigen receptor (CAR)-engineered Natural Killer cells to solid tumors for use as a novel combination therapy.
Using oncolytic viruses to enhance trafficking and infiltration of chimeric antigen receptor (CAR)-engineered Natural Killer cells to solid tumors for use as a novel combination therapy.
使用溶瘤病毒增强嵌合抗原受体（CAR）工程自然杀伤细胞向实体瘤的运输和浸润，用作新型联合疗法。
批准号：
458550
负责人：
Portillo Ana
金额：
$7.65万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer is the most common cancer affecting women worldwide. Triple negative breast cancer (TNBC) accounts for 12-15% of cases, and is the most aggressive form of breast cancer with the highest ability to spread. Currently, there are no approved tar
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
